|
PROGRAM NAME
|
ESR Facility Seed Activity
|
|
OBJECTIVES
|
Support new research directions by assisting in gathering of data the will enhance competitiveness for external funding
|
|
AWARD
|
Pilot experiments only; facility user fees waived
|
|
CONDITIONS
|
Investigator supports supply costs
|
|
ELIGIBILITY
|
Students, tenure-track faculty, research scientists
|
|
DEADLINE
|
None
|
|
NOTIFICATION OF ACTION
|
N/A
|
|
HOW TO APPLY
|
Contact ESR Facility
|
|
ADDITIONAL INFORMATION
|
Garry Buettner, 68 EMRB, 5-6749
|
|
PROGRAM NAME
|
Residency Research Program
|
|
OBJECTIVES
|
Train otolaryngology residents in medical research
|
|
AWARD
|
Up to $2,500
|
|
CONDITIONS
|
Must be approved by Departmental Research Committee
|
|
ELIGIBILITY
|
Must be Otolaryngology resident
|
|
DEADLINE
|
Plan submitted during R2 year
|
|
NOTIFICATION OF ACTION
|
Approved during R2 year
|
|
HOW TO APPLY
|
Contact person below
|
|
ADDITIONAL INFORMATION
|
Richard Tyler, Chair, Otolaryngology Research Committee, C21-6 GH, 6-2471
|
|
PROGRAM NAME
|
Gastroenterology-Hepatology Training Program
|
|
OBJECTIVES
|
Prepare MDs and Ph.D.s for investigation of diseases relevant to the digestive system
|
|
AWARD
|
Salary and limited supply and travel budgets
|
|
CONDITIONS
|
N/A
|
|
ELIGIBILITY
|
Must be permanent U.S. resident who has obtained MD or Ph.D. degree
|
|
DEADLINE
|
Variable
|
|
NOTIFICATION OF ACTION
|
Variable, depending on deadline
|
|
HOW TO APPLY
|
Obtain application materials from contact person below
|
|
ADDITIONAL INFORMATION
|
Joel Weinstock, Internal Medicine, Division of Gastroenterology-Hepatology, 4607 JCP, 6-3792
|
|
PROGRAM NAME
|
Carver Medical Research Initiative Grants |
|
OBJECTIVES
|
Funding for faculty who have novel research ideas with long-range potential but need to gather preliminary data before submitting an external proposal.
|
|
AWARD
|
Up to $30,000
|
|
CONDITIONS
|
None Specified
|
|
ELIGIBILITY
|
Assistant, Associate or Full Professor in College of Medicine or College of Public Health
|
|
DEADLINE
|
December 1
|
|
NOTIFICATION OF ACTION
|
February 1
|
|
HOW TO APPLY
|
|
|
ADDITIONAL INFORMATION
|
|
PROGRAM NAME
|
Carver Trust Foundation Collaborative Pilot Grants |
|
OBJECTIVES
|
Seed funding for novel pilot collaborative research to allow PI's to gather preliminary data to submit an external grant.
|
|
AWARD
|
Up to $50,000
|
|
CONDITIONS
|
None Specified
|
|
ELIGIBILITY
|
Assistant, Associate or Full Professor in College of Medicine or College of Public Health
|
|
DEADLINE
|
December 1
|
|
NOTIFICATION OF ACTION
|
February 1
|
|
HOW TO APPLY
|
See guidelines and submit application at the Carver Trust Medical Research Initiatives website.
|
|
ADDITIONAL INFORMATION
|
David Bush, CCOM Research Administrator
|
|
PROGRAM NAME
|
Holden Comprehensive Cancer Center -- Aiming for A Cure Foundation Grant Opportunity |
|
OBJECTIVES
|
Supports cancer research with a special interest in, but not limited to, childhood cancers.
|
|
AWARD
|
$100,000 with a maximum of two years to expend all funds.
|
|
CONDITIONS
|
Up to 10% of the budget can be used for faculty salary. The purchase of equipment is discouraged, as are funds for travel.
|
|
ELIGIBILITY
|
Any faculty or staff member at University of Iowa may apply. The research project must be conducted on the UI campus.
|
|
DEADLINE
|
Letter of intent due Noon, April 27, 2018. Full proposal for those selected to move forward due Noon, June 15, 2018.
|
|
NOTIFICATION OF ACTION
|
N/A
|
|
HOW TO APPLY
|
Submit Letter of Intent to Tami Thompson at HCCC (tami-thompson@uiowa.edu). Include as a single PDF: Title page, Summary, and NIH biosketch.
|
|
ADDITIONAL INFORMATION
|
Contact: Holden Comprehensive Cancer Center Administration, 319-353-8620. Full guidelines link: https://uihc.org/cancer-research-funding-opportunities |
|
PROGRAM NAME
|
Holden Comprehensive Cancer Center - Seed Grants - American Cancer Society |
|
OBJECTIVES
|
For junior faculty members a one-year, cancer-focused research award supported through the Holden Comprehensive Cancer Center's American Cancer Society Institutional Research Grant. The purpose of these seed grant awards is to foster research in cancer that cannot readily be supported through other available sources, and to permit the initiation of promising new projects or novel ideas necessary to obtain the preliminary results for junior faculty to successfully compete for national research grants.
|
|
AWARD
|
Up to $30,000 per award
|
|
CONDITIONS
|
Applicants are not eligible if they have grant support from a national agency, have previously served as P.I. on peer-reviewed grants from a national agency (even if such funding has expired), or if they have received prior support from the American Cancer Society. Recipients must submit a progress report, summarizing the results of the study supported by the ACS-IRG, with information on published papers and grant support as a result of, and separately from, the seed grant support received for the project, and copies of all publications resulting from the work. Annual updates will be required for five years.
|
|
ELIGIBILITY
|
Eligibility is limited to fully affiliated University of Iowa junior faculty (Associates, Assistant Professors, Instructors, or Research Scientists) within six years of their first independent research or faculty appointment. Research must be conducted at the University of Iowa. These awards are intended for junior faculty who are eligible to apply for NIH R01 grants, but who have NOT obtained such a grant. Senior faculty members (higher than Assistant Professor or equivalent), post-doctoral fellows, fellow associates are not eligible to apply. Applicants are NOT eligible if they have received grant support from a national agency, have previously served as P.I. on peer-reviewed grants from a national agency (even if such funding has expired), or if they have received prior support from the ACS. The ACS guidelines stipulate that no awards are to be made to investigators pursing any project funded by the tobacco industry. All applicants are required to verify their eligibility through their Departmental Chair.
|
|
DEADLINE
|
Noon, Monday, November 5, 2018
|
| NOTIFICATION |
Notification of awards will be made early December 2018.
|
|
HOW TO APPLY
|
Guidelines available on Holden website. |
|
ADDITIONAL INFORMATION
|
Questions may be directed to Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities.
|
|
PROGRAM NAME
|
Holden Comprehensive Cancer Center - Vere D. Wenger Travel Award |
|
OBJECTIVES
|
Vere Wenger funds are avaiable to support partial travel expenses of faculty and staff members in all fields (humanities, law, medicine, natural and social sciences, etc.) from all colleges at the University of Iowa who present papers at conferences and/or who attend professional meetings which contribute to the knowledge of cancer or for the well-being of cancer patients.
|
|
AWARD
|
Awards up to $750 for only one fiscal year, if the applicant has no other grant or departmental funding available.
|
|
CONDITIONS
|
Awards made only in cases where other sources of funding unavailable or inadequate; research must contribute to knowledge of cancer or deal with ways to increase the well-being of cancer patients. Decisions concerning use of funds are made by the leaders of the four formal research programs of the HCCC. Awards must be applied for and approved before the meeting has occurred.
|
|
ELIGIBILITY
|
All University of Iowa faculty and staff
|
|
DEADLINE
|
Open
|
|
NOTIFICATION OF ACTION
|
Requests are considered upon receipt of application and as funds remain available.
|
|
HOW TO APPLY
|
Inquries from HCCC members and others should be made to the program leader most appropriate for the research being supported. Click here for more information.
1) Letter defining details of dates, location and sponsor of meeting.
2) Letter of acceptance of the paper or a program listing the presentation
3) Brief (2 paragraph) explanation of how the paper relates to cancer or cancer patients
4) Abstract of the paper
5) Endorsement by Leader of Holden Cancer Center Research Program.
|
|
ADDITIONAL INFORMATION
|
Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities.
|
|
PROGRAM NAME
|
|
|
OBJECTIVES
|
The Holden Comprehensive Cancer Center will award one prize of $25,000 from the Donald D. Dorfman Endowment for the best research papers in leukemia and lymphoma published in 2017-2019.
|
|
AWARD
|
The amount of the award is $25,000. A plaque will be presented to the recipients at a recognition event to be held 11:00-12:00 on Monday, July 29, 2019, with members of the Dorfman family present.
|
|
CONDITIONS
|
Eligible papers are to be published in peer-reviewed journals in 2017-2019, or accepted for publication and currently in press.
|
|
ELIGIBILITY
|
Recipient must be a member of the Holden Comprehensive Cancer Center. Nomination of publications representing major collaborative efforts with other institutions, including those involving colleagues from the Iowa/Mayo Lymphoma SPORE, are encouraged. Authors should have made major contributions to the nominated publications (but do not necessarily need to be first or senior author). Applicants may submit more than one paper, but each paper will be reviewed individually. Recipients of the Dorfman Award from the last cycle are not eligible.
|
|
DEADLINE
|
Deadline for submission: Noon, Monday, July 1, 2019.
|
|
NOTIFICATION OF ACTION
|
Applicants will be notified of the award in July, 2019, with a Recognition Event and presentation of Award Plaque to be held 11:00-12:00 on Monday, July 29, 2019.
|
|
HOW TO APPLY
|
Applicants should submit a single PDF with a copy of the publication and a Cover Letter, which identifies the contact person with name, title, address, telephone number, the full reference, a brief summary describing why you feel the paper is deserving of the award. The summary should include the key issues addressed in the manuscript, a description of the impact of your paper on these issues and the role the applying investigator played on the paper. Failure to provide the summary and identifying key issues will negatively impact on the review of the manuscript. Please forward a single PDF document to: Tami Thompson.
|
| ADDITIONAL INFORMATION |
Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities.
|
|
PROGRAM NAME
|
Institutional Research Fellowship for Kidney Disease, Hypertension, and Cell Biology
|
|
OBJECTIVES
|
To support postdoctoral fellows or potential postdoctoral fellows whose research projects relate to one or more of these areas: kidney disease, hypertension, cell biology.
|
|
AWARD
|
None Specified
|
|
CONDITIONS
|
None Specified
|
|
ELIGIBILITY
|
Applicants must be a U.S. citizen or Green Card holder, have received an M.D. or Ph.D. degree (or equivalent), and may not have received more than three years of support from a National Research Service Award.
|
|
DEADLINE
|
None Specified
|
|
NOTIFICATION OF ACTION
|
None Specified
|
|
HOW TO APPLY
|
Candidates interested in applying for this award are invited to inquire at the Nephrology Division office (356-3446).
|
|
ADDITIONAL INFORMATION
|
|
PROGRAM NAME
|
Holden Comprehensive Cancer Center - SPORE Career Enhancement Program (CEP) |
|
OBJECTIVES
|
The University of Iowa / Mayo Clinic Lymphoma Specialized Program of Research Excellence (UI/MC Lymphoma SPORE) is a center grant funded through the National Cancer Institute. The program is designed to train junior faculty in translational, multidisciplinary research in lymphoma or to support established senior investigators who wish to change their research trajectory to translational lymphoma research. The duration of the award is for one year with a possible second year, based on exceptional progress and continued translational trajectory of the awardee. Career Enhancement Program awardees will have priority access to Lymphoma SPORE core resources: Biospecimens, Biostatistics, and Clinical Trials.
|
|
AWARD
|
A maximum of $25,000 per year in direct costs will be provided through the Iowa/Mayo SPORE grant with support from each institution for a total award of approximately $50,000. The exact amount of the award is contingent on NIH funding. Funds must be spent by June 30, 2020.
|
|
CONDITIONS
|
Should the investigator discontinue the project, or leave the designated institution, the UI/MC Lymphoma SPORE must be notified two months in advance of these changes. Failure to comply with this policy may jeopardize any future awards to the institution(s). Unexpended funds from the award must be returned to the UI/MC Lymphoma SPORE within 60 days.
|
|
ELIGIBILITY
|
This program focuses on two types of candidates:
-- Laboratory investigators at the senior post-doctoral or junior faculty (Instructor, Assistant Professor, Associate Consultant, Research Associate, or Research Scientist) who have demonstrated outstanding research potential and have an interest in a career in translational lymphoma research, but are not yet independently funded to perform this research. More experienced successful investigators with an interest in shifting their focus towards translational lymphoma research, are also eligible.
-- Clinicians who have demonstrated interest and ability in translational research during their clinical fellowship training, are committed to careers in translational research, and wish additional research training in pursuit of this career.
|
|
DEADLINE
|
The deadline for the Letter of Concept is Noon (Central Time), Friday, April 12, 2019. (Invited only) The deadline for the Invited Full Proposal is Noon (Central Time), Friday, May 17, 2019. |
|
NOTIFICATION OF ACTION
|
June 2019 |
|
HOW TO APPLY
|
|
|
ADDITIONAL INFORMATION
|
For additional information, please contact Tami Thompson 319-353-8987 or Karla Stout 319-353-8634 karla-stout@uiowa.edu or view the Holden Comprehensive Cancer Center (HCCC) Research Funding website.
|
|
PROGRAM NAME
|
Holden Comprehensive Cancer Center - SPORE Developmental Research Projects |
|
OBJECTIVES
|
The University of Iowa / Mayo Clinic Lymphoma Specialized Program of Research Excellence (UI/MC Lymphoma SPORE) is a center grant funded through the National Cancer Institute. The goal of the SPORE is to encourage and support translational research that will ultimately benefit patients with, or at risk for lymphoma. More specifically, funds will be awarded to pilot projects that explore innovative ideas (particularly projects that translate basic science discoveries into the clinic) which will have significant impact on reducing incidence and mortality, and increasing and improving survival in lymphoma. Developmental Research Program awardees will have priority access to SPORE core resources: Biospecimens, Biostatistics, and Clinical Research. The project duration is one year.
|
|
AWARD
|
A maximum of $25,000 per year in direct costs will be provided through the Iowa/Mayo SPORE grant with support from each institution for a total award of approximately $50,000. The exact amount of the award is contingent on NIH funding. NIH funds must be spent by June 30, 2020. No overhead expenses will be paid to the applicant organization and the purchase of equipment is not allowed. All budgetary requests must be justified.
|
|
CONDITIONS
|
Should the investigator discontinue the project, or leave the designated institution, the UI/MC Lymphoma SPORE must be notified two months in advance of these changes. Failure to comply with this policy may jeopardize any future awards to the institution(s). The investigator may apply for transfer of the grant. If the transfer is not approved, unexpended portions of the grant must be returned to the UI/MC Lymphoma SPORE within sixty days.
|
|
ELIGIBILITY
|
Investigators planning to conduct their research in universities, hospitals, research institutions, and federal agencies are eligible to apply. Applicants must hold either a PhD or MD degree or equivalent.
|
|
DEADLINE
|
The deadline for the Letter of Concept is Noon (Central Time), Friday, April 12, 2019.
(Invited only) The deadline for the Invited Full Proposal is Noon (Central Time), Friday, May 17, 2019.
|
|
NOTIFICATION OF ACTION
|
June 2019
|
|
HOW TO APPLY
|
|
|
ADDITIONAL INFORMATION
|
For additional information, please contact Tami Thompson 319-353-8987 or Karla Stout 319-353-8634 karla-stout@uiowa.edu or view the Holden Comprehensive Cancer Center (HCCC) Research Funding website.
|
|
PROGRAM NAME
|
|
|
OBJECTIVES
|
Diana Benz Seed Grant Opportunity for Support of cancer research seed grant geared towards psychosocial issues, complementary and alternative medicine, and other aspects of cancer research with a focus on quality of life for cancer patients and survivors.
|
|
AWARD
|
Up to $20,000 per award
|
|
CONDITIONS
|
The principal investigator must have a full-time affiliation with the University of Iowa and should intend to carry out the research project on campus.
|
|
ELIGIBILITY
|
Any faculty or staff member at the University of Iowa is eligible.
|
|
DEADLINE
|
Noon, Monday, November 21, 2016
|
|
NOTIFICATION OF ACTION
|
Notification of awards will be made in December 2016.
|
|
HOW TO APPLY
|
Contact Cancer Center Administration, 5970Z JPP, 353-8620 or download the guidelines.
|
|
ADDITIONAL INFORMATION
|
Holden Comprehensive Cancer Center Administration, 353-8620. For information on the Holden Comprehensive Cancer Center (HCCC) funding opportunities, please visit https://uihc.org/cancer-research-funding-opportunities.
|
| PROGRAM NAME | NET SPORE Career Enhancement Program (CEP) Letter of Concept (LOC) due May 31, 2019 |
| OBJECTIVES | The University of Iowa Neuroendocrine Tumor Specialized Program of Research Excellence (NET SPORE) is a center grant funded though the National Cancer Institute. The mission of the NET SPORE Career Enhancement Program is toward basic scientists or clinicians interested in translational research acquiring additional skills to become translational researchers in neuroendocrine tumors. |
| AWARD | One or two recipients will receive a maximum award of up to $100,000 per year in direct costs provided through the Iowa NET SPORE grant and (for University of Iowa applicants) matching institutional funds for University of Iowa applicants. Applicants outside of the University of Iowa note that the $100,000 includes your institution’s F&A. NIH funds must be spent by August 31, 2020. |
| CONDITIONS | See complete announcement on website. Budget period September 1, 2019 to August 31, 2020. |
| ELIGIBILITY |
This program focuses on two types of candidates: 1. Laboratory investigators at the senior post-doctoral or junior faculty level (Assistant Professor or Research Scientist) who demonstrate outstanding research potential and are interested in a career in translational neuroendocrine tumor research, but are not yet independently funded to perform this research. Experienced, successful investigators interested in shifting toward translational neuroendocrine tumor research are also eligible. 2. Clinicians who demonstrate interest and ability in translational research, are committed to careers in translational research, and wish to devote a major portion of their early faculty career to additional research training are encouraged to apply. |
| DEADLINE | Letter of Concept (LOC) due Friday, May 31, 2019. For selected LOC only - full proposal deadline is Thursday, August 1, 2019. |
| NOTIFICATION | Selected LOC notification expected June 15, 2019. Full proposal due August 1, 2019. Final award notice on or before August 26, 2019. |
| HOW TO APPLY | Guidelines available on Holden website. |
| ADDITIONAL INFORMATION | Questions may be directed to Karla Stout at karla-stout@uiowa.edu or the Program Director listed in each opportunity PDF. For information about the Holden Comprehensive Cancer Center (HCCC) research, please click here. |
| PROGRAM NAME | NET SPORE Developmental Research Program (DRP) Letter of Concept (LOC) due May 31, 2019 |
| OBJECTIVES | The University of Iowa Neuroendocrine Tumors Specialized Program of Research Excellence (NET SPORE) is a center grant funded through the National Cancer Institute. The mission of the NET SPORE Developmental Research Program is to encourage innovative laboratory and clinical studies in neuroendocrine tumor research, and to provide funds to support previously untested hypotheses or other innovative research objectives that address problems in neuroendocrine cancer. |
| AWARD | One or two recipients will receive a maximum award of up to $50,000 per year in direct costs provided through the Iowa SPORE grant and (for University of Iowa applicants) matching institutional funds. Applicants outside of the University of Iowa note that the $50,000 includes your institution’s F&A. NIH funds must be spent by August 31, 2020 |
| CONDITIONS | See complete announcement on website. Budget period September 1, 2019 to August 31, 2020. |
| ELIGIBILITY | Investigators planning to conduct their research in universities, hospitals, research institutions, and federal agencies are eligible to apply. Applicants must hold either a PhD or MD degree or equivalent. Applicants may be of any rank including resident, fellow, associate, assistant professor, associate professor, or professor. Applicants do not need to hold a position at the University of Iowa but do need to collaborate with faculty at the University of Iowa and utilize at least one of the SPORE cores (Administration, Biospecimens, Bioinformatics/Biostatistics, Clinical Trials). |
| DEADLINE | Letter of Concept (LOC) due Wednesday, May 31, 2019. For selected LOC only - full proposal deadline is August 1, 2019 |
| NOTIFICATION | Selected LOC notification before June 15, 2019. Full Proposal due August 1, 2019. Final award notice on or before August 26, 2019. |
| HOW TO APPLY | Guidelines available on Holden website. |
| ADDITIONAL INFORMATION | Questions may be directed to Karla Stout at karla-stout@uiowa.edu or the Program Director listed in each PDF. For information about the Holden Comprehensive Cancer Center (HCCC) research, please click here |